Loading...

FITC anti-mouse CD3 Antibody

Pricing & Availability
Clone
17A2 (See other available formats)
Regulatory Status
RUO
Other Names
T cell antigen receptor complex, T3
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
17A2
C57BL/6 splenocytes stained with 17A2 FITC and 145-2C11 PE
  • 17A2
    C57BL/6 splenocytes stained with 17A2 FITC and 145-2C11 PE
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
100203 50 µg 29€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100204 500 µg 115€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD3, also known as T3, is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3 is composed of CD3ε, δ, γ and ζ chains. It forms a TCR complex by associating with TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
γδTCR-positive T-T hybridoma D1
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Additional reported application (for relevant formats) include: spatial biology (IBEX)1,2.

Application References
  1. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  2. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  2. Zhang H, et al. 2021. Front Immunol. 12:644520. PubMed
  3. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  4. Lee JH, et al. 2022. EBioMedicine. 77:103903. PubMed
  5. Zhu Y, et al. 2022. Nat Commun. 13:4282. PubMed
  6. Harel M, et al. 2020. J Immunol. 205:1167. PubMed
  7. Bruno MEC, et al. 2022. J Cell Physiol. 237:706. PubMed
  8. Pei J, et al. 2022. J Virol. 96:e0194221. PubMed
  9. Li X, et al. 2022. J Clin Invest. 132: . PubMed
  10. Meng J, et al. 2022. Cell Rep. 38:110492. PubMed
  11. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  12. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  13. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  14. Wu J, et al. 2023. Bioact Mater. 20:259. PubMed
  15. Shen CY, et al. 2022. Pharmaceutics. 14: . PubMed
  16. Brigo N, et al. 2022. Bio Protoc. 12:e4440. PubMed
  17. Hong Y, et al. 2022. J Leukoc Biol. 112:425. PubMed
  18. Mugarza E, et al. 2022. Sci Adv. 8:eabm8780. PubMed
  19. Xie DH, et al. 2022. Med Phys. 49:6728. PubMed
  20. Gong F, et al. 2023. Adv Healthc Mater. 12:e2201771. PubMed
  21. Gao Y, et al. 2022. Cell Res. 32:1086. PubMed
  22. Chen Y, et al. 2023. Adv Healthc Mater. 12:e2202085. PubMed
  23. Wei M, et al. 2022. Front Immunol. 13:1017574. PubMed
  24. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  25. You Q, et al. 2023. Adv Mater. 35:e2204910. PubMed
  26. Kim HI, et al. 2022. Molecules. 27: . PubMed
  27. Shi C, et al. 2023. Nat Nanotechnol. 18:86. PubMed
  28. Yang H, et al. 2023. Cell Death Differ. 30:560. PubMed
  29. Yu J, et al. 2022. Nat Commun. 13:7903. PubMed
  30. Schepers M, et al. 2023. Brain Behav Immun. 109:1. PubMed
  31. Ding L, et al. 2023. J Clin Invest. 133: . PubMed
  32. Peng Q, et al. 2023. EMBO Rep. 24:e56034. PubMed
  33. Jin SM, et al. 2023. Nat Nanotechnol. :. PubMed
  34. Liu H, et al. 2023. Cell Death Differ. :. PubMed
  35. Tsioti I, et al. 2023. J Neuroinflammation. 20:25. PubMed
  36. Gon Y, et al. 2023. PLoS One. 18:e0279389. PubMed
  37. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  38. Zhang W, et al. 2022. Dev Cell. 57:329. PubMed
  39. Meacham CE, et al. 2022. Nat Cell Biol. 24:697. PubMed
  40. Reticker-Flynn NE, et al. 2022. Cell. 185:1924. PubMed
  41. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  42. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  43. Jiang W, et al. 2017. Sci Rep. 7:6501. PubMed
  44. Harsha Krovi S, et al. 2020. Nat Commun. 4.790277778. PubMed
  45. Dai L, et al. 2020. Cell. 182(3):722-733.e11. PubMed
  46. Xing J, et al. 2021. Cell Reports. 35(12):109205. PubMed
  47. Zaman R, et al. 2021. Immunity. :. PubMed
  48. Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed
  49. Peng J, et al. 2023. Am J Reprod Immunol. 89:e13678. PubMed
  50. Chen H, et al. 2023. Nat Commun. 14:941. PubMed
  51. Wang F, et al. 2023. Int J Mol Sci. 24:. PubMed
  52. Liu HJ, et al. 2023. Nat Commun. 14:1214. PubMed
  53. Guo D, et al. 2023. Cell Biosci. 13:51. PubMed
  54. Dang YZ, et al. 2023. Neoplasma. 70:123. PubMed
  55. Wang Y, et al. 2023. Front Bioeng Biotechnol. 11:1128268. PubMed
  56. Sambandam A, et al. 2023. Heliyon. 9:e14238. PubMed
  57. Masle-Farquhar E, et al. 2023. Front Immunol. 14:1095257. PubMed
  58. Tao Q, et al. 2023. Microbiol Spectr. :e0522922. PubMed
  59. Tan X, et al. 2023. Adv Sci (Weinh). 10:e2206768. PubMed
  60. Zhang YN, et al. 2023. Nat Commun. 14:1985. PubMed
  61. Ito M, et al. 2023. Sci Rep. 13:5939. PubMed
  62. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  63. Kuang C, et al. 2023. Nat Commun. 14:2093. PubMed
  64. Zuo B, et al. 2023. Clin Transl Oncol. . PubMed
  65. Bhaskar A, et al. 2023. iScience. 26:106644. PubMed
  66. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
  67. Wang D, et al. 2023. Nat Commun. 14:2943. PubMed
  68. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  69. Feng X, et al. 2023. Nat Commun. 14:3208. PubMed
  70. Zeng S, et al. 2023. Front Oncol. 13:1171926. PubMed
  71. Lan Y, et al. 2023. iScience. 26:106817. PubMed
  72. Yang QC, et al. 2023. iScience. 26:106916. PubMed
  73. Liu, C., Guo, J., et al. 2025. Stroke Vasc Neurol. 10(5),582-593. PubMed
  74. Gawish R, et al. 2022. Elife. 11:. PubMed
  75. Qiao Y, et al. 2021. Oncoimmunology. 10:1947569. PubMed
  76. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  77. Manukian G, et al. 2021. Int J Radiat Oncol Biol Phys. 110:1341. PubMed
  78. Jiang Q, et al. 2022. Theranostics. 12:59. PubMed
  79. Wilhelm J, et al. 2021. J Control Release. 329:353. PubMed
  80. Ford K, et al. 2020. Cancer Res. 80:1846. PubMed
  81. Delvecchio FR, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1543. PubMed
  82. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  83. Tang L, et al. 2021. Oncol Lett. 22:605. PubMed
  84. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  85. Lin W, et al. 2020. Theranostics. 10:4871. PubMed
  86. Miller CM, et al. 2020. J Virol. 94:00:00. PubMed
  87. Boyd DF, et al. 2020. Nature. 587:466. PubMed
  88. Wu X, et al. 2012. Biochem Pharmacol. 84:1164. PubMed
  89. Turner JA, et al. 2020. Immunity. 53:1202. PubMed
  90. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  91. Choi YY, et al. 2021. Cell Death Dis. 12:826. PubMed
  92. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  93. Zhang S, et al. 2022. Acta Pharm Sin B. 12:3124. PubMed
  94. Steubing RD, et al. 2022. Brain Behav Immun Health. 24:100493. PubMed
  95. Mei S, et al. 2022. Front Immunol. 13:911164. PubMed
  96. Lu H, et al. 2021. Autophagy. 17:2511. PubMed
  97. Du Q, et al. 2019. Front Microbiol. 10:2050. PubMed
  98. Song C, et al. 2019. Nat Commun. 10:3745. PubMed
  99. Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed
  100. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  101. Bromley SK, et al. 2020. Cell Reports. 32(9):108085. PubMed
  102. Bao H, et al. 2020. Mol Med Rep. 4.675. PubMed
  103. Diao L, et al. 2022. iScience. 25:105511. PubMed
  104. Bangs DJ, et al. 2022. Cell Rep. 38:110266. PubMed
  105. Huang Y, et al. 2021. Radiother Oncol. 162:34. PubMed
  106. Zhao J, et al. 2022. J Nanobiotechnology. 20:62. PubMed
  107. Ren J, et al. 2021. Theranostics. 11:304. PubMed
  108. Tan X, et al. 2021. Front Oncol. 11:768222. PubMed
  109. Oliva Chávez AS, et al. 2021. Nat Commun. 12:3696. PubMed
  110. Liu Q, et al. 2021. Cell Death Dis. 12:240. PubMed
  111. Sun CC, et al. 2020. Genome Med. 0.553472222. PubMed
  112. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  113. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  114. Dolgova EV, et al. 2022. Int J Mol Sci. 23:. PubMed
  115. Mostafavi H, et al. 2022. PLoS Pathog. 18:e1010185. PubMed
  116. Sala D, et al. 2022. Mol Ther Methods Clin Dev. 25:170. PubMed
  117. Antonia O Cuff et al. 2017. Wellcome open research. 2:39 . PubMed
  118. Davis FM, et al. 2019. Arterioscler Thromb Vasc Biol. 39:2353. PubMed
  119. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  120. Lesmeister M, et al. 2005. Reprod Biol Endocrinol. 29:74. PubMed
  121. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  122. Deng P, et al. 2022. Cells. 11:. PubMed
  123. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  124. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  125. Ning X, et al. 2019. Mol Cell. 74:19. PubMed
  126. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  127. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  128. Jiang S, et al. 2020. Scand J Immunol. e12867:91. PubMed
  129. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  130. White C, et al. 2014. J Immunol. 193:5933. PubMed
  131. Chen Y, et al. 2012. PLoS One. 7:e47190. PubMed
  132. Dang Y, et al. 2022. Cancer Cell Int. 22:88. PubMed
  133. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  134. Geng T, et al. 2022. Methods Mol Biol. 2585:71. PubMed
  135. Solanki A, et al. 2018. Development. 145. PubMed
  136. Shields BD, et al. 2019. Cancer Res. 79:1113. PubMed
  137. Lee M, et al. 2014. PLoS One. 9:112666. PubMed
  138. Mingozzi F, et al. 2016. EMBO Mol Med. 8: 1039 - 1051. PubMed
  139. Carr RM, et al. 2021. Nat Commun. 12:2901. PubMed
  140. Pervaiz N, et al. 2021. Pigment Cell Melanoma Res. 34:918. PubMed
  141. Sun Y, et al. 2022. Nat Commun. 13:3916. PubMed
  142. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  143. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  144. Kimball AS et al. 2019. Immunity. 51(2):258-271 . PubMed
  145. Naing A et al. 2019. Cell reports. 26(5):1242-1257 . PubMed
  146. Yang S, et al. 2019. Nat Commun. 10:2782. PubMed
  147. Littwitz-Salomon E, et al. 2021. Nat Commun. 12:5376. PubMed
  148. Hanasoge Somasundara AV, et al. 2021. Cell Rep. 37:110099. PubMed
  149. Shi R, et al. 2022. Theranostics. 12:875. PubMed
  150. Jie X, et al. 2022. J Immunother Cancer. 10:. PubMed
  151. Wang X, et al. 2018. Mol Med Rep. 17:1660. PubMed
  152. Lee JS et al. 2018. Cell. 174(6):1559-1570 . PubMed
  153. Comazzetto S et al. 2018. Cell stem cell. 24(3):477-486 . PubMed
  154. Chen Q, et al. 2016. Nat Commun. 7:13193. PubMed
  155. Bogie JF, et al. 2020. Ther Adv Chronic Dis. 11:2040622320947378. PubMed
  156. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  157. Omori S, et al. 2021. Cell Reports. 34(6):108734. PubMed
  158. Ding Y, et al. 2022. Cell Death Dis. 13:996. PubMed
  159. Tang X, et al. 2022. Cell Rep. 41:111673. PubMed
  160. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  161. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  162. Zhou H, et al. 2022. Oncoimmunology. 11:2057892. PubMed
  163. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  164. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  165. Koren E, et al. 2022. Nat Commun. 13:4628. PubMed
  166. Zhang C, et al. 2022. Nat Commun. 13:3468. PubMed
  167. Chen X, et al. 2021. Cell Rep. 37:109991. PubMed
  168. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  169. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  170. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  171. Sreekumar PG, et al. 2018. J Control Release. 283:94. PubMed
  172. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  173. Li W, et al. 2019. Nat Commun. 10:3349. PubMed
  174. Xu X, et al. 2018. Cell. 175:1336. PubMed
  175. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  176. Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed
  177. Harb H, et al. 2021. Immunity. 54(6):1186-1199.e7. PubMed
  178. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  179. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  180. Akhter N, et al. 2016. J Biol Chem. 291: 23672 - 23680. PubMed
  181. Huang B, et al. 2015. PLoS One. 10: 0134715. PubMed
  182. Markey K, et al. 2014. J Immunol. 192:5426. PubMed
  183. Liu W, et al. 2021. Cell Death Discov. 7:136. PubMed
  184. França TT, et al. 2021. JCI Insight. 6:. PubMed
  185. Carbone C, et al. 2021. J Immunother Cancer. 9:. PubMed
  186. Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed
  187. Sun C, et al. 2022. J Adv Res. 35:71. PubMed
  188. Moon HG et al. 2018. Immunity. 49(2):275-287 . PubMed
  189. Ren W, et al. 2018. Mucosal Immunol. 12:531. PubMed
  190. Du J, et al. 2012. Stem Cells. 30:1447. PubMed
  191. Weinheimer-Haus E, et al. 2014. PLoS One. 9:91355. PubMed
  192. Zheng L, et al. 2020. Front Oncol. 10:531131. PubMed
  193. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  194. Yang Z, et al. 2021. Onco Targets Ther. 14:4239. PubMed
  195. Puigdelloses M, et al. 2021. J Immunother Cancer. 9:. PubMed
  196. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  197. Port JR, et al. 2020. J Virol. 94:. PubMed
  198. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  199. Li Y, et al. 2021. Cell Death Dis. 12:1001. PubMed
  200. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  201. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  202. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  203. Ma W, et al. 2017. Cell Death & Disease. 10.1038/cddis.2017.47. PubMed
  204. Alsina-Sanchis E, et al. 2020. Mol Cancer Res. . PubMed
  205. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  206. Yu H, et al. 2021. Front Oncol. 11:736882. PubMed
  207. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  208. Zhang R, et al. 2022. Front Pharmacol. 13:870848. PubMed
  209. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  210. Yang Z, et al. 2021. Nat Commun. 12:4852. PubMed
  211. Pandit M, et al. 2021. Eur J Immunol. 51:1461. PubMed
  212. Lingegowda H, et al. 2022. Front Reprod Health. 3:726936. PubMed
  213. Zhang W, et al. 2019. Mar Drugs. 0.845138889. PubMed
  214. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  215. Zhang W, et al. 2020. Nat Commun. 11:1187. PubMed
  216. Yi H, et al. 2021. Front Immunol. 12:719189. PubMed
  217. Qi J, et al. 2021. Nat Commun. 12:4755. PubMed
  218. Bent EH, et al. 2021. Nat Commun. 12:6218. PubMed
  219. Zhang YN, et al. 2021. Sci Adv. 7:eabj3107. PubMed
  220. Murdock BJ, et al. 2021. JCI Insight. 6:. PubMed
  221. Robertson TF, et al. 2021. J Cell Biol. 220:. PubMed
  222. Mohammadi MR, et al. 2021. Commun Biol. 4:685. PubMed
  223. Li X, et al. 2021. Cell Death Dis. 12:314. PubMed
  224. He J, et al. 2020. Evid Based Complement Alternat Med. 2020:5637507. PubMed
  225. Roy S, et al. 2019. Front Immunol. 2.404166667. PubMed
  226. Scally S, et al. 2017. Nat Commun. . 10.1038/s41467-017-01924-3. PubMed
  227. Wang Z, et al. 2021. Acta Pharm Sin B. 694:11. PubMed
  228. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  229. Wu L, et al. 2020. Cell Rep. 33:108327. PubMed
  230. Zan H, et al. 2017. Nat Commun. 8:14244. PubMed
  231. Cabrera-Perez J, et al. 2016. J Immunol. 197: 1692 - 1698. PubMed
  232. Kang J, Lee J, Chang J 2016. PLoS One. 11: 0157015. PubMed
  233. Cabrera-Perez C, et al. 2015. J Immunol . 194:1609-20. PubMed
  234. Zhang X, et al. 2021. Nat Commun. 12:4536. PubMed
  235. Smith-Díaz CC, et al. 2021. Front Oncol. 11:709543. PubMed
  236. Tsai HI, et al. 2021. EMBO Mol Med. 13:e12834. PubMed
  237. Wang J, et al. 2022. Clin Transl Med. 12:e718. PubMed
  238. Lai Y, et al. 2022. Clin Transl Med. 12:e999. PubMed
  239. Zhang J, et al. 2022. Biomater Res. 26:44. PubMed
  240. Li M, et al. 2021. Br J Pharmacol. 178:2617. PubMed
  241. Yang YS, et al. 2022. Nat Commun. 13:6175. PubMed
  242. Chen X, et al. 2019. Med Sci Monit. 25:5389. PubMed
  243. Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed
  244. Nam J, et al. 2021. Adv Ther (Weinh). 4:. PubMed
  245. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  246. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  247. Yang Z, et al. 2021. Nat Commun. 12:4299. PubMed
  248. van den Berk P, et al. 2020. Cell Rep. 33:108533. PubMed
  249. Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
  250. Chen C, et al. 2020. Front Cell Neurosci. 14:8. PubMed
  251. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  252. Harb H, et al. 2020. Nat Immunol. 1359:21. PubMed
  253. Campolo M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  254. Jiang Y, et al. 2021. Nat Commun. 12:742. PubMed
  255. Magee JA, et al. 2021. Stem Cell Reports. 16:20. PubMed
  256. Fujimoto M, et al. 2022. Nat Commun. 13:5408. PubMed
  257. Cané S, et al. 2021. J Immunother Cancer. 9:. PubMed
  258. Ravindran Menon D, et al. 2021. Pharmaceuticals (Basel). 14:. PubMed
  259. Le QV, et al. 2022. Bioact Mater. 15:160. PubMed
  260. Aulova KS, et al. 2022. Molecules. 27:. PubMed
  261. Yang N, et al. 2022. Nat Commun. 13:2336. PubMed
  262. Jia H, et al. 2018. Int J Oncol. 53:949. PubMed
  263. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  264. Xu Y, et al. 2016. Nat Commun. 7:12073. PubMed
  265. Zheng DW, et al. 2020. Nat Commun. 3.865972222. PubMed
  266. Tao Z, et al. 2022. Cells. 11:. PubMed
  267. Tang T, et al. 2022. J Immunother Cancer. 10:. PubMed
  268. Zhou Y, et al. 2022. Theranostics. 12:5488. PubMed
  269. Chen LH, et al. 2021. Sci Rep. 11:19478. PubMed
  270. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  271. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  272. Wang F, et al. 2021. Neoplasia. 23:281. PubMed
  273. Pan X, et al. 2019. BMC Complement Altern Med. 19:163. PubMed
  274. Li K, et al. 2020. Nat Commun. 0.795138889. PubMed
  275. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  276. Zukauskas A, et al. 2018. mSphere. 3:e00303. PubMed
  277. Guo X, et al. 2020. J Cell Mol Med. . PubMed
  278. Simoni L, et al. 2020. Cell Rep. 33:108330. PubMed
  279. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  280. Mincham KT, et al. 2021. Front Immunol. 11:601494. PubMed
  281. Zheng Y, et al. 2022. Transl Res. :. PubMed
  282. Gawish R, et al. 2022. Elife. 11:. PubMed
  283. Li J, et al. 2022. Nat Commun. 13:1481. PubMed
  284. Tanegashima K et al. 2017. EBioMedicine. 24:247-256 . PubMed
  285. Crowe J, et al. 2020. PLoS Pathog. 16:e1008391. PubMed
  286. Tur J, et al. 2020. Cell Reports. 32(8):108079. PubMed
  287. Roberto MP, et al. 2021. Immunity. 54(8):1807-1824.e14. PubMed
  288. Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
  289. Sun Q, et al. 2022. J Inflamm Res. 15:5827. PubMed
  290. Cao Y, et al. 2022. Small. 18:e2203466. PubMed
  291. Li C, et al. 2022. Front Cell Dev Biol. 10:913824. PubMed
  292. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  293. Pastor Arroyo EM, et al. 2022. Clin Sci (Lond). 136:557. PubMed
  294. Erens C, et al. 2022. Biomedicines. 10:. PubMed
  295. Zhang J, et al. 2021. Stem Cell Res Ther. 12:579. PubMed
  296. Gu Z, et al. 2021. Nat Genet. 53:672. PubMed
  297. Zuo S, et al. 2021. EBioMedicine. 64:103240. PubMed
  298. Zheng QY, et al. 2020. FASEB J. 34:10590. PubMed
  299. Martínez-Vicente P, et al. 2019. PLoS Pathog. 15:e1007658. PubMed
  300. Liu WL, et al. 2019. Nat Commun. 10:3199. PubMed
  301. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
  302. Li J, et al. 2021. eLife. 10:00. PubMed
  303. Trivedi S, et al. 2020. Elife. 9:00. PubMed
  304. Tripathi D, et al. 2016. Nat Commun. 7:13896. PubMed
  305. Fan X, et al. 2014. PLoS One. 9:107638. PubMed
RRID
AB_312660 (BioLegend Cat. No. 100203)
AB_312661 (BioLegend Cat. No. 100204)

Antigen Details

Structure
Ig superfamily, CD3/TCR, 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
Antigen recognition, TCR signal transduction, T cell activation
Ligand/Receptor
Peptide antigen/MHC-complex
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12502 View all products for this Gene ID
UniProt
View information about CD3 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD3 Reagents Request Custom Conjugation
Description Clone Applications
Brilliant Violet 711™ anti-mouse CD3 17A2 FC
Biotin anti-mouse CD3 17A2 FC,IHC-F
PE/Dazzle™ 594 anti-mouse CD3 17A2 FC
APC/Fire™ 750 anti-mouse CD3 17A2 FC
Brilliant Violet 750™ anti-mouse CD3 17A2 FC
TotalSeq™-A0182 anti-mouse CD3 17A2 PG
TotalSeq™-B0182 anti-mouse CD3 17A2 PG
Spark Blue™ 550 anti-mouse CD3 17A2 FC
Spark NIR™ 685 anti-mouse CD3 17A2 FC
TotalSeq™-C0182 anti-mouse CD3 17A2 PG
APC/Fire™ 810 anti-mouse CD3 17A2 FC
PE/Fire™ 640 anti-mouse CD3 17A2 FC
Spark YG™ 570 anti-mouse CD3 17A2 IHC-F
PE/Fire™ 700 anti-mouse CD3 17A2 FC
FITC anti-mouse CD3 17A2 FC
PE anti-mouse CD3 17A2 FC
Purified anti-mouse CD3 17A2 FC,IHC-F,IP,ICC
Alexa Fluor® 647 anti-mouse CD3 17A2 FC,IHC-F,3D IHC,SB
Alexa Fluor® 488 anti-mouse CD3 17A2 FC,IHC-F,3D IHC
Pacific Blue™ anti-mouse CD3 17A2 FC
Alexa Fluor® 700 anti-mouse CD3 17A2 FC
PerCP/Cyanine5.5 anti-mouse CD3 17A2 FC
PE/Cyanine7 anti-mouse CD3 17A2 FC
APC/Cyanine7 anti-mouse CD3 17A2 FC
Brilliant Violet 421™ anti-mouse CD3 17A2 FC,ICC
Brilliant Violet 570™ anti-mouse CD3 17A2 FC
Brilliant Violet 650™ anti-mouse CD3 17A2 FC
Brilliant Violet 785™ anti-mouse CD3 17A2 FC
Brilliant Violet 510™ anti-mouse CD3 17A2 FC
APC anti-mouse CD3 17A2 FC
Ultra-LEAF™ Purified anti-mouse CD3 17A2 FC,IHC-F,IP,ICC
Brilliant Violet 605™ anti-mouse CD3 17A2 FC
Alexa Fluor® 594 anti-mouse CD3 17A2 IHC-F,FC,3D IHC,SB
PE/Cyanine5 anti-mouse CD3 17A2 FC
Spark Blue™ 574 anti-mouse CD3 Antibody 17A2 FC
Spark Violet™ 423 anti-mouse CD3 17A2 FC
PE/Fire™ 810 anti-mouse CD3 17A2 FC
Spark Red™ 718 anti-mouse CD3 17A2 FC
Spark UV™ 387 anti-mouse CD3 17A2 FC
PerCP/Fire™ 780 anti-mouse CD3 Antibody 17A2 FC
PerCP anti-mouse CD3 Antibody 17A2 FC
Spark YG™ 581 anti-mouse CD3 (Flexi-Fluor™) 17A2 FC
Spark YG™ 593 anti-mouse CD3 (Flexi-Fluor™) Antibody 17A2 FC
Spark PLUS B488™ anti-mouse CD3 17A2 FC
Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account